Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03981796
Title A Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer (RUBY)
Recruitment Active, not recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors Tesaro, Inc.
Indications

endometrial cancer

Therapies

Carboplatin + Paclitaxel

Carboplatin + Dostarlimab-gxly + Paclitaxel

Age Groups: adult | senior
Covered Countries USA | ITA | ESP | DEU | CAN | BEL


No variant requirements are available.